BeiGene, a global oncology company, unites the world against cancer by delivering innovative, affordable medicines faster. With 15 years of investment, BeiGene’s world-class clinical development, research, and manufacturing capabilities set industry benchmarks for speed and efficiency. Boasting over 1,100 top scientists, BeiGene drives one of the largest, most productive oncology research teams and pipelines. Its fully integrated manufacturing accelerates clinical development while ensuring high-quality production of small-molecule, biologics, and emerging therapeutics. Committed to sustainability, BeiGene enhances operational resilience and business continuity.
Our fully integrated manufacturing capabilities also allow us to speed-up our clinical development efforts while ensuring the highest-quality production of our clinical and commercial portfolio of small-molecule, biologics and emerging modality therapeutics.